Company
Company

Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Sherlock Biosciences

Main focus: Development of novel Cas-enzymes for diagnostics

Company stage: Commercial (diagnostics), pre-clinical (therapeutics)

Diseases: COVID-19 (diagnostics)

Genome editing tool: CRISPR-Cas12a, CRISPR-Cas12b, CRISPR-Cas13.

Funding stage: Private

Location: Cambridge, MA, USA

Website: https://sherlock.bio/

Partners: Tolo Biotech

Sherlock Biosciences is a CRISPR diagnostics company. The company deploys its SHERLOCK™- and INSPECTR™-platforms that are based on novel Cas-enzymes, and so far, it has commercialised a novel CRISPR-based SARS-CoV-2 detection kit. The company is co-founded by Feng Zhang, who also co-founded Arbor Biotechnologies and Beam Therapeutics.

Tags

HashtagSherlock Biosciences, Inc.

Company: Sherlock Biosciences
Jobs, banner ads, webinars, sponsored content...
close
Search CRISPR Medicine